Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades

.

Source: Expert Opinion on Therapeutic Patents - April 4, 2024 Category: Drugs & Pharmacology Authors: Md Toufiqur RahmanHetti Handi Chaminda LakmalJaveena HussainChunyang JinCenter for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, USA Source Type: research